Cabecera

Call Type: JOB OFFERS

Call Info

23-256_DL_R Posdoctoral Researcher - Gynecologic Cancer

Application Submission process

From: 24/10/2023 00:00 (UTC+01:00) Brussels, Copenhagen, Madrid, Paris

To: 07/11/2023 23:59 (UTC+01:00) Brussels, Copenhagen, Madrid, Paris

Info:

 

Posdoctoral Researcher - Gynecologic Cancer

REF: 23-256_R_DL

 

About the research group

Gynecologic Cancer Group

The Gynecologic Cancer group at IDIBELL is actively focused on the identification of genes (coding and non-coding) that are essential for the development and progression of gynecological malignancies (mainly, but not exclusively, endometrial cancer) to ultimately discover novel therapeutic avenues to implement precision medicine in this field. In order to achieve this our group is engaged in multiple projects covering an array of techniques at both in vitro and in vivo level (CRISPR whole genome screenings, RNA_sequencing, proteomics, metabolomics, patient-derived orthoxenografts, etc) and focusing on several key major cellular processes such as autophagy. More information can be found at www.llobetnavaslab.org.

About the role

The candidate will work on a project related to womb cancer, immunooncology, therapy resistance and autophagy. The candidate will use a set of in vitro/in vivo models to study: (1) the role of autophagy during endometrial tumorigenesis and (2) the development of novel chemical compounds aimed at targeting the autophagy machinery for therapeutic purposes. We also expect the candidate to engage the project semi-autonomously and to participate in other side-projects carried out in the laboratory.

Job requirements

Professional experience

  • We seek for a motivated individual with previous grounded experience in the cancer arena, especially in the molecular and cellular biology field. Previous work in endometrial cancer will be valued.

Education and training

  •  Bachelor plus Masters and PhD (already defended or in the process of) in life sciences or biomedical sciences. 

Technical & soft skills

  • Strong background in molecular and cell biology techniques (e.g., PCR, western blot, cloning, mutagenesis, CRISPR-based gene editing, viral transduction) and animal experimentation

Languages

  • Good command of the English language

 

What do we offer

  • No. of positions: 1

  • Estimated start date: 08/11/2023

  • Contract duration: 2 years

  • Estimated annual gross salary: 36.978€
  • You will be part of a multicultural team. We have a fun loving and friendly international work environment.

  • Flexible working schedule - We know you have a life outside of work and we will work with you to make sure it's kept that way.
  • Possibility to work some days in remote -Teleworking

  • 26 working days of holiday per year

  • System of accumulated hours for employees, from 88 to 104 hours depending on the year (11 to 13 working days), to attend to personal matters.

  • Paid leave package

  • Benefits of constant training are offered

  • We offer and promote diverse and inclusive conditions. Applicants are made free from any discrimination. Specifically IDIBELL works to improve gender equality in all areas with the aim of achieving gender balance, but maintaining the most scrupulous respect to any choice at the level of gender identity. Please express yourself freely, safely and non-binarily, if that's the case.

Deadline: Please submit your application by  07/11/2023

Data protection notice

In compliance with the obligations established in the General Regulation of Data Protection (RGPD), which is the Regulation (EU) 2016/679 of the Parliament and of the Council, of April 27, 2016, and the Organic Law 3/2018, of December 5, Protection of Personal Data and guarantee of digital rights, it is reported that the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), CIF G58863317, with address Av. Granvia de l'Hospitalet, 199-203, 08908, L'Hospitalet de Llobregat, will process your personal data, as the controller, to apply for the position, maintain communication concerning the status of the candidature, to access the delivered CV; to compare that your data is in accordance with the offers announced by IDIBELL and to verify, where appropriate, that the information provided is accurate. You can find more information in our Privacy Policy at https://idibell.cat/en/privacy-policy-2/, request more information about the data processing carried out and exercise your rights of access, rectification, deletion, opposition, portability, limitation of processing by sending a request at email: dataprotection@idibell.cat. If you consider that you have not obtained satisfaction in exercising your rights, you may submit a claim to Catalan Data Protection Authority.

Our institute

IDIBELL is a research center that integrates the biomedical research of the Bellvitge University Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens.

Observations:

The 'HR Excellence in Research' award represents IDIBELL’s commitment to the implementation of Human Resources policies, which oversee the attracting and development of talent in an open, transparent, and based on personal merit, in alignment with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment Researchers (Charter and Code).

IDIBELL is committed to the principles of the Code of Conduct for the Recruitment of Researchers of the European Commission and the implementation of open, transparent and merit-based recruitment (OTMR).

   
Documentation

Call Document